Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Short Communication Volume 7 Issue 3

Effective Natural Products BioChaga and BioDihydroquercetin to Safe Assistance to the Body at all Stages of COVID-19 Viral Infection

O Usolceva*

Irkutsk State Medical University, Russia

*Corresponding Author: O Usolceva, Irkutsk State Medical University, Russia.

Received: February 06, 2023; Published: February 10, 2023

Abstract

The rapid outbreak of coronavirus infection is a global public health problem worldwide. In a pandemic, the issue of creating effective antiviral drugs for the treatment of a new coronavirus infection is most acute. The issue of prevention is also acute. Each of us would like to know what he can do to protect his body from the threat of coronavirus infection. So far, effective treatments have not yet been developed. The scarcity of clinically proven drugs has contributed to the fact that natural products have received increasing attention due to their low toxicity and lack of side effects.

Keywords: BioChaga; BioDihydroquercetin; COVID-19

References

  1. André Fischer., et al. “Novel coronavirus protease inhibitors. 687 million compounds identified by virtual screening”. Department of Pharmaceutical Sciences, University of Basel.
  2. Nesterovsky YuE., et al. “Headache and other neurological symptoms in the structure of the clinical picture of a new coronavirus infection (COVID-19)”. Nervous Diseases 2 (2020): 60-68.
  3. Tatarinov VV., et al. “Dihydroquercetin as a potential immunonutrient in the complex therapy of COVID-19”. (2021).
  4. Melanie Rike-Hoch., et al. “Prostaglandin E2-mediated immune response impairment contributes to severe COVID-19 disease”.
  5. "Specialists of the Novosibirsk "Vector" have shown the effectiveness of chaga extract against SARS-CoV-2”. (2020).
  6. Danilenko SA. “Correction of microcirculation disorders in patients with chronic obstructive pulmonary disease with dihydroquercetin”. Siberian Medical Journal3 (2010): 59-62.
  7. Bizyuk LA and Korolevich MP. “Antioxidant dihydroquercetin: clinical and pharmacological efficacy and synthesis pathways”. Medical Business: Scientific and Practical Therapeutic Journal 1 (2013): 13-19.
  8. Kubatiev AA. “Dikvertin is an effective inhibitor of platelet aggregation of flavonoid nature Questions of Biological”. Medical and Pharmaceutical Chemistry 3 (1999): 47-51.
  9. Salova TYu and Gromova NYu. “Theoretical aspects of obtaining biologically active substances from plant and animal raw materials”. Successes of Modern Natural Science 3 (2016): 39-43.
  10. Balandaikin ME. “On the question of the study of the chemical structure and medicinal properties of Inonotus obliquus (PERS.) Pil”. Chemistry of Plant Raw Materials 2 (2013): 15-22.

Citation

Citation: O Usolceva. “Effective Natural Products BioChaga and BioDihydroquercetin to Safe Assistance to the Body at all Stages of COVID-19 Viral Infection”.Acta Scientific Medical Sciences 7.3 (2023): 82-84.

Copyright

Copyright: © 2022 O Usolceva. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is March 30, 2023.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US